Prostate Cancer > About this site > Sources

Links for "National Cancer Institute (NCI)"

#	Title and Source	Quality
1	Epirubicin and docetaxel in treating patients with metastatic prostate cancer Last updated: Ongoing	77%
2	Phase I study of epirubicin and docetaxel in patients with metastatic androgen-independent adenocarcinoma of the prostate Last updated: Ongoing	77%
3	ET-743 in men with advanced prostate cancer Last updated: Ongoing	77%
4	General information about prostate cancer Last updated: 2005	77%
5	Genetic analysis of hereditary prostate cancer Last updated: Ongoing	77%
6	Genetics of prostate cancer - introduction Last updated:	77%
7	Hormone therapy and docetaxel or hormone therapy alone in treating patients with metastatic prostate cancer Last updated: Ongoing	77%
8	Phase III randomized study of hormonal therapy and docetaxel versus hormonal therapy alone in patients with metastatic prostate adenocarcinoma Last updated: Ongoing	77%
9	Hormone therapy with or without docetaxel and estramustine in treating patients with prostate cancer that is locally advanced or at high risk of relapse Last updated: Ongoing	77%
10	Phase III randomized study of neoadjuvant releasing factor agonist therapy and antiandrogen therapy with or without docetaxel and estramustine in patients with locally advanced prostate cancer or with a high risk of relapse Last updated: Ongoing	77%

Epirubicin and docetaxel in treating patients with metastatic prostate cancer